Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1995-1-31
|
pubmed:abstractText |
A total of 58 patients have undergone bilateral pelvic lymphadenectomy as a staging procedure for clinically localized adenocarcinoma of the prostate. Of these, 19 patients (33%) had pelvic lymph node involvement. When a cutoff value of 50 ng/ml was used, the preoperative prostate-specific antigen (PSA) value had a positive predictive value of 57% for pelvic lymph node metastasis. Of the patients with PSA < 20 ng/ml, only 1 (4%) had evidence of lymph node metastasis. None of the patients with well-differentiated tumor (Gleason 2-4) had lymphatic spreading. In contrast, 82% of patients with poorly differentiated tumor (Gleason 8-10) had positive pelvic lymph nodes. Those patients with high PSA (> or = 20 ng/ml) and high Gleason's score (> or = 8) had the highest incidence of nodal extension (90%).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0302-2838
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
202-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7528661-Aged,
pubmed-meshheading:7528661-Humans,
pubmed-meshheading:7528661-Lymph Node Excision,
pubmed-meshheading:7528661-Lymphatic Metastasis,
pubmed-meshheading:7528661-Male,
pubmed-meshheading:7528661-Middle Aged,
pubmed-meshheading:7528661-Predictive Value of Tests,
pubmed-meshheading:7528661-Prostate-Specific Antigen,
pubmed-meshheading:7528661-Prostatic Neoplasms
|
pubmed:year |
1994
|
pubmed:articleTitle |
Prediction of lymphatic spreading in prostatic cancer by prostate-specific antigen and Gleason's score.
|
pubmed:affiliation |
Department of Surgery, Veterans General Hospital-Taipei, Taiwan, Republic of China.
|
pubmed:publicationType |
Journal Article
|